Practical Training Exercise
ANALYZING AND MANAGING RISKS
IN LIFE SCIENCES RESEARCH
Based on the article by Ben Salah, G, et al. “An Interethnic variability
and functional prediction of DNA repair gene polymorphisms: the
example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a
healthy Tunisian population.” Mol Biol Rep. 2012; 39: 9639-9647.
1
2
This exercise was developed by Center for Science, Technology and Security
Policy at the American Association for the Advancement of Science (AAAS).
This work is licensed by AAAS under a Creative Commons Attribution-
NonCommercial-ShareAlike 3.0 United States License.
You may contact the copyright holder at:
1200 New York Ave.
Washington, DC 20002
1-202-326-6493
This series of case study exercises was developed with input from: Lindsey
Marburger, Nisreen AlHmoud, Oussama ben Fradj, Eleanor Celeste,
Gwenaële Coat, Cristine Geers, Irene Jillson, Abdulaziz Kaed, Rawan
Khasawneh, Fadia Maki, Kimberly Schaub, and Kavita Berger.
Developed with the support of the Department of State,
Biosecurity Engagement Program.
3
2
1
3
Learning Objectives
Develop the skills to think critically about risks and risk
mitigation strategies needed in your own scientific
environment;
Enhance your ability to identify risk management strategies
and approaches that minimize identified risks and maintain
the high-quality and utility of the scientific activity; and
Apply the risk analysis framework to your own or your peers’
scientific activities.
Participant Expectations
1. The definitions of different types of risks associated with laboratory, field, and public health research.
2. The process of risk analysis—risk identification, assessment, management, and communication—including:
– How to identify and assess risks by considering the possible likelihood and consequences of risks, and the risks versus benefits of a research activity,
– Strategies for managing risks, and
– Who, when, and how to communicate risks.
3. How to apply the risk analysis framework to your own scientific activities.
By the end of this exercise, you will have familiarity with:
4
5
3
2
1
4
Ground Rules for Participation
Prior to starting this exercise, participants should have read the case study
article.
Ask the facilitator to clarify questions about the case study article.
Focus on understanding and analyzing the diverse risks involved in the
research rather than on critiquing the methodologies or research choices of
the authors.
Interact with one another in a way that encourages open communication and
exchange of ideas. For example, listen to everyone’s ideas respectfully.
You may want to take your own notes to enhance your ability to actively
participate in the training activity.
5
Biorisk Glossary
6
These definitions are from the WHO’s Responsible Life Science for Global Health
Security: A Guidance Document
Misuse Theft Accidental
Exposure Environmental
Release
Animal Subjects
Care and Use Human Subjects
Research
Falsification,
Fraud, Plagiarism
Responsible Research Spectrum
Deliberate Misconduct Negligence and Bad Practice Research Ethics
• Bioethics
• Biorisk
• Biorisk reduction
• Laboratory biosafety
• Laboratory biosecurity
• Dual-use life sciences research
• Research excellence
Additional concepts:
• Protection of human subjects
• Protection of animal subjects
• Responsible
research/responsible conduct of
research
4
3
2
1
7
Your risk review will follow these 4 stages:
Risk Analysis Framework
Risk Identification
Risk Assessment
Risk Management
Risk Communication
1. Risk Identification 2. Risk Assessment
process by which researchers identify needed resources and consider biosafety/biosecurity recommendations.
Also defined as the “process of evaluating the risk(s) arising from a hazard(s), taking into account the adequacy of any existing controls and deciding whether or not the risk(s) is acceptable).” (OHSAS 18001: 2007)
Asks the questions:
• How likely are the risks to occur?
• What are the potential consequences if the risks occur?
• Do the risks outweigh the benefits?
process by which researchers consider
all possible internal, external, and
organizational risks.
Asks the question:
• What are the possible risks
associated with the research?
8
3. Risk Management 4. Risk Communication
process by which researchers consider
regulations/guidelines, training, and SOP
compliance issues.
Asks the question:
• What risk management strategies
could minimize the likelihood that the
risk will occur or the consequences if
the risks occurred?
Possible strategies: physical barriers,
personnel training or vetting, regulations and
laws, and/or alternative experiments
process by which researchers consider
communication strategies, non-
compliance issues and
approval/modification processes.
Asks the questions:
• What risks should be
communicated with ethics or
other research review committees
prior to project initiation?
• What risks should be
communicated to research
participants or fellow researchers
during the research project?
• What risks, if any, might come
from sharing research data or
results?
• What strategies could be used to
minimize the risks?
Risk Analysis Chart
10
CASE
STUDY
.
An Interethnic variability and functional prediction of DNA repair gene polymorphisms: the example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy Tunisian population
Ben Salah, G, et al. “An Interethnic variability and functional prediction of DNA repair gene
polymorphisms: the example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy
Tunisian population.” Mol Biol Rep. 2012; 39: 9639-9647.
Outline of Case Study
Part 1: Research Question/Hypothesis
Part 2: Background Information Overview
Part 3: Research Methodology
Part 4: Risk Analysis in the Research Article
Part 5: Research Results and Conclusions
12
Research Question/Hypothesis
DNA repair is critically important for maintaining genome stability and normal cellular and organismal functions.
Mutations in the protein XRCC3 (involved in homologous recombination repair) and XPD (involved in nucleotide excision repair) have been linked to cancer.
The prevalence of these mutations “are not randomly distributed throughout the human population, but follow diverse ethnic and/or geographic-specific patterns.”
The authors proposed to examine the prevalence of these mutations in the Tunisian population and carry out bioinformatic analysis to assess whether the mutations are deleterious in the Tunisian population.
Research Statement:
13
Background Information Overview
14
DNA Repair
Changes in DNA can occur through
individual base deletions, additions, or
substitutions; single stranded breaks;
and double stranded breaks.
DNA repair is a critical cellular function
to fix breaks in the DNA before they
cause major damage.
Repair can be done through correcting
individual bases (nucleotide excision
repair) or repairing major damage
(homologous recombination repair).
Homologous
Recombination
Photo Credit: Bianco et al.,
1998
Nucleotide Excision
Repair
Photo Credit: Laura
Mitchell, 2011
Background Information Overview
15
XRCC3 and Homologous Recombination Repair (HRR)
• XRCC3 is X-ray repair cross-complementing group 3
• XRCC3 is thought to repair chromosomal fragmentation, translocations, and deletions
• XRCC3 is a member of the Rad-51 family of proteins and interacts with other family proteins to carry out its role in homologous recombination repair
• The Thr241>Meth is the most common mutation and is associated with low DNA repair capacity, which could lead to cancer.
XRCC3 and HRR.
Photo Credit: Skorski, 2002.
Background Information Overview
16
XPD/ERCC2 and Nucleotide Excision Repair
Photo Credit: Cameroni, et al, 2010
XPD is xeroderma
pigmentation
complementation group D
It is a ATPase/helicase
involved in nucleotide
excision repair and
transcription
The Lys751>Gln mutation is
linked to lower DNA repair
capacity by altering the
properties of the DNA repair
enzyme, which is a complex
of proteins.
.
Research Methodology
• Patient Inclusion: Healthy, unrelated individuals (154 men and women from South Tunisia) were recruited to participate in the study. Participants provided their social habits and health problems on a standard questionnaire. Individuals with a history of cancer were excluded.
• DNA Extraction and Sample Genotyping: Blood samples were collected from participants and DNA was extracted using standard procedures. Fragments from the XRCC3 and XPD genes were amplified by polymerase chain reaction (PCR). Restriction fragment length polymorphism (RFLP) analysis was conducted on the amplified fragments.
• Bioinformatics Analysis: The HapMap database was used to determine which mutations/polymorphisms were associated with different ethic and geographic groups. Sorting intolerant from tolerant (SIFT) software and analysis was used to predict whether the mutations might affect protein function. The SIFT predictions were verified by Polymorphism Phenotyping, version 2.2 software.
• Statistical Analysis: Standard statistical analyses were conducted on the data to calculate the allele frequency and compare the relatedness between alleles found in the Tunisian and HapMap populations.
17
Risk Analysis in this Research Article
While risk analysis is an important part of science, few scientific
publications include in-depth descriptions of how the authors
assessed and managed risk.
Today your task is to perform a risk analysis based on this
research article.
To begin, answer the following question:
Based on your current knowledge of the experimental procedures or
research purpose, what risks might be important to consider in
designing, carrying out, or communicating this research?
18
Risk Identification
An Interethnic variability and functional prediction of DNA repair gene polymorphisms: the
example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy Tunisian
population
19
Questions
What, if any, are the potential biosafety risks (including collection and handling of human blood
samples) to researchers and staff?
What, if any, are the possible safety and ethical risks to the patients who participate in this study?
What risks, if any, are associated with collecting information about study participants?
Could this research be used to cause harm, either misuse of research information, materials and
results?
Risk Assessment
An Interethnic variability and functional prediction of DNA repair gene polymorphisms: the
example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy Tunisian
population
20
Question
What aspect of this research or procedural steps might pose the most severe consequences to
patients? What are those consequences and how likely are they?
What aspect of this research or procedural steps might pose the most severe consequences to
researchers? What are those consequences and how likely are they?
What are the resources, expertise, training, and tools that could be useful in assessing
the risks identified for this research project?
Risk Management
An Interethnic variability and functional prediction of DNA repair gene polymorphisms: the
example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy Tunisian
population
21
Question
What international, national, and institutional laws, regulations, policies, and best practices could
minimize the identified risks of the research project?
What are the minimum laboratory safety and security protocols and infrastructure (including
equipment) that should be in place before beginning this research project?
What additional approaches could be used to minimize the identified risks of the research
project?
What, if any, specialized competencies, skills, and training are needed to successfully carry out
this research?
What could the research team do in advance to limit the risk of sensitive personal information
being accessed?
Research Results and Conclusions
Results Conclusions
• The data provides the
foundation to further study the
relationship of the XRCC3 and
XPD mutations to cancer risk
and DNA repair variability in
the Tunisian population.
• According to genetic analyses of the XRCC2
and XPD genes, the Tunisian population is
closely related to the Caucasian population from
European ancestry.
• The XPD genetic analysis suggests a
relationship between the Tunisian population
and people who originated from Gujarat, India.
• The p.Thr241>Met mutation of XRCC3 is
potentially damaging and could affect ATP-
binding and DNA repair efficiency. This mutation
affects homologous recombination repair.
• The pLys7521>Gln mutation of XPD might be
tolerated. The mutation affects the ATP-binding
site of XPD and destroys his helicase activity.
Although this mutation affects nucleotide
excision repair, it does not affect transcription
activity.
22
Risk Communication
An Interethnic variability and functional prediction of DNA repair gene polymorphisms: the
example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy Tunisian
population
23
Question
What are the risks that should be communicated during this research? To whom?
How would you communicate the risks and risk management steps to an IRB or ethics committee?
What data and information protection measures should be implemented to protect the safety and
anonymity of research participants?
What, if any, social or cultural sensitivities are associated with the study? What approaches can be
used to minimize these sensitivities when research results are discussed at conferences, between
project researchers, and in publication?
What approaches could be used to communicate any risks and risk mitigation strategies to other
researchers and the public?
Final Exercise: Risk in
Your Own Research
1. Identification: What are the primary risks you face in your research? Think about the risks to you and other
researchers and technicians in the field, clinic, and/or lab, the general public, the environment and economy,
your institution, and human and animal subjects.
2. Assessment: What are the consequences of the identified risks if they occur? How likely are they to occur?
Based on your assessment of the potential consequences, are there are there any risks that could harm
people, animals, crops, or the economy?
What resources, capabilities, and skills are needed to mitigate these risks?
3. Management: What strategies could you use or resources you could refer to minimize or mitigate these
risks? (These strategies should not decrease the quality of the research.) For ideas of possible strategies and
resources, consider those discussed in this practical exercise and from your own experiences.
Are there any risks associated with your research that cannot be adequately mitigated?
4. Communication: What risks, if any, are associated with communicating your research during the design or
conduct of the research? What risks, if any, are associated with communicating the research results at
scientific conferences and in publications? What strategies could you use to mitigate the risks? Are there any
stakeholders with whom you must share or should share the risks of your research? Your findings?
Perform a risk analysis of your own research. Choose one past,
ongoing, or future research project to analyze:
24
Example Risk Analysis Strategy
25
Communicate
“Laboratory risk management.” CWA 15793: 2011
Reference List
26
Background Information and Data Ben Salah, G, et al. “An Interethnic variability and functional prediction of DNA repair gene polymorphisms: the example of XRCC3 (pThr241>Met) and XPD (pLys751>Gln) in a healthy Tunisian population.” Mol Biol Rep. 2012; 39: 9639-9647.
World Health Organization, Responsible Life Science for Global Health Security: A Guidance Document. 2010; http://whqlibdoc.who.int/hq/2010/WHO_HSE_GAR_BDP_2010.2_eng.pdf.
Diagrams and Photos Bianco, Peiro R., Robert B. Tracy and Stephen C. Kowalczykowski. “DNA STRAND EXCHANGE PROTEINS: A BIOCHEMICAL AND PHYSICAL COMPARISON.” Frontiers in Bioscience 3, d570-603. June 17, 1998. Available at: http://www.bioscience.org/1998/v3/d/bianco/3.htm.
Cameroni, E, Stettler, K and Suter, B. On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations. Cell Div. 15 Sept 2010. 5; 24.
European Committee for Standardization (CEN). CEN Workshop Agreement: CWA 15793. “Laboratory biorisk management.” Ref. No: CWA 15793:2011 D/E/F. September 2011: 17. Available at: ftp://ftp.cenorm.be/CEN/Sectors/TCandWorkshops/Workshops/CWA15793_September2011.pdf.
Laura Mitchell. “Study Flashcards.” Biology 400 with Lee at Northern Arizona University. October 24, 2011. Available at: www.studyblue.com
Tomasz Skorski. Oncogenic tyrosine kinases and the dna-damage response. Nature Reviews Cancer. 2002; 2; 351-360.